Elisabeth Löwdin

Human plasma protein levels alter the in vitro antifungal activity of caspofungin: An explanation to the effect in critically ill?

Kurland, Siri; Löwdin, Elisabeth; Furebring, Mia; Shams, Ayda et al.

Ingår i Mycoses, s. 79-87, 2022

• DOI för Human plasma protein levels alter the in vitro antifungal activity of caspofungin: An explanation to the effect in critically ill?
• Ladda ner fulltext (pdf) av Human plasma protein levels alter the in vitro antifungal activity of caspofungin: An explanation to the effect in critically ill?

Pharmacokinetics of Caspofungin in Critically Ill Patients in Relation to Liver Dysfunction: Differential Impact of Plasma Albumin and Bilirubin Levels

Kurland, Siri; Furebring, Mia; Löwdin, Elisabeth; Eliasson, E. et al.

Ingår i Antimicrobial Agents and Chemotherapy, 2019

• DOI för Pharmacokinetics of Caspofungin in Critically Ill Patients in Relation to Liver Dysfunction: Differential Impact of Plasma Albumin and Bilirubin Levels

Elimination ability of caspofungin in critically ill patients in relation to liver dysfunction in an ICU setting

Kurland, Siri; Furebring, Mia; Löwdin, Elisabeth; Nielsen, Elisabet I. et al.

Ingår i Mycoses, s. 225-225, 2017

Korsallergi mellan penicilliner och övriga betalaktam­antibiotikaRisken är betydligt mindre än man tidigare trott: [Cross allergy between penicillins and other beta lactam antibiotics--the risk is much less than previously thought]

Tängdén, Thomas; Furebring, Mia; Löwdin, Elisabeth; Werner, Sonja

Ingår i Läkartidningen, 2015

Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model

Tängdén, Thomas; Adler, Marlen; Cars, Otto; Sandegren, Linus et al.

Ingår i Journal of Antimicrobial Chemotherapy, s. 1319-1326, 2013

• DOI för Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model

Human plasma protein levels alter the in vitro antifungal activity of caspofungin: An explanation to the effect in critically ill?

Kurland, Siri; Löwdin, Elisabeth; Furebring, Mia; Shams, Ayda et al.

Ingår i Mycoses, s. 79-87, 2022

• DOI för Human plasma protein levels alter the in vitro antifungal activity of caspofungin: An explanation to the effect in critically ill?
• Ladda ner fulltext (pdf) av Human plasma protein levels alter the in vitro antifungal activity of caspofungin: An explanation to the effect in critically ill?

Pharmacokinetics of Caspofungin in Critically Ill Patients in Relation to Liver Dysfunction: Differential Impact of Plasma Albumin and Bilirubin Levels

Kurland, Siri; Furebring, Mia; Löwdin, Elisabeth; Eliasson, E. et al.

Ingår i Antimicrobial Agents and Chemotherapy, 2019

• DOI för Pharmacokinetics of Caspofungin in Critically Ill Patients in Relation to Liver Dysfunction: Differential Impact of Plasma Albumin and Bilirubin Levels

Elimination ability of caspofungin in critically ill patients in relation to liver dysfunction in an ICU setting

Kurland, Siri; Furebring, Mia; Löwdin, Elisabeth; Nielsen, Elisabet I. et al.

Ingår i Mycoses, s. 225-225, 2017

Korsallergi mellan penicilliner och övriga betalaktam­antibiotikaRisken är betydligt mindre än man tidigare trott: [Cross allergy between penicillins and other beta lactam antibiotics--the risk is much less than previously thought]

Tängdén, Thomas; Furebring, Mia; Löwdin, Elisabeth; Werner, Sonja

Ingår i Läkartidningen, 2015

Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model

Tängdén, Thomas; Adler, Marlen; Cars, Otto; Sandegren, Linus et al.

Ingår i Journal of Antimicrobial Chemotherapy, s. 1319-1326, 2013

• DOI för Frequent emergence of porin-deficient subpopulations with reduced carbapenem susceptibility in ESBL-producing Escherichia coli during exposure to ertapenem in an in vitro pharmacokinetic model

Voriconazole-induced inhibition of the fungicidal activity of amphotericin B in Candida strains with reduced susceptibility to voriconazole: an Effect Not Predicted by the MIC Value Alone

Lignell, Anders; Löwdin, Elisabeth; Cars, Otto; Sanglard, Dominique et al.

Ingår i Antimicrobial Agents and Chemotherapy, s. 1629-1637, 2011

• DOI för Voriconazole-induced inhibition of the fungicidal activity of amphotericin B in Candida strains with reduced susceptibility to voriconazole: an Effect Not Predicted by the MIC Value Alone

Posaconazole in human serum: A greater pharmacodynamic effect than predicted by the non-protein-bound serum concentration

Lignell, Anders; Löwdin, Elisabeth; Cars, Otto; Chryssanthou, Erja et al.

Ingår i Antimicrobial Agents and Chemotherapy, s. 3099-3104, 2011

• DOI för Posaconazole in human serum: A greater pharmacodynamic effect than predicted by the non-protein-bound serum concentration

Foreign Travel Is a Major Risk Factor for Colonization with Escherichia coli Producing CTX-M-Type Extended-Spectrum beta-Lactamases: a Prospective Study with Swedish Volunteers

Tängdén, Thomas; Cars, Otto; Melhus, Åsa; Löwdin, Elisabeth

Ingår i Antimicrobial Agents and Chemotherapy, s. 3564-3568, 2010

• DOI för Foreign Travel Is a Major Risk Factor for Colonization with Escherichia coli Producing CTX-M-Type Extended-Spectrum beta-Lactamases: a Prospective Study with Swedish Volunteers

Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers.

Tängdén, Thomas; Cars, Otto; Melhus, Åsa; Löwdin, Elisabeth

Ingår i Antimicrobial Agents and Chemotherapy, s. 3564-3568, 2010

Characterization of the inhibitory effect of voriconazole on the fungicidal activity of amphotericin B against Candida albicans in an in vitro kinetic model

Lignell, Anders; Löwdin, Elisabeth; Cars, Otto; Sjölin, Jan

Ingår i Journal of Antimicrobial Chemotherapy, s. 142-8, 2008

• DOI för Characterization of the inhibitory effect of voriconazole on the fungicidal activity of amphotericin B against Candida albicans in an in vitro kinetic model

Semimechanistic pharmacokinetic/pharmacodynamic model for assessment of activity of antibacterial agents from time-kill curve experiments

Nielsen, Elisabet I.; Viberg, Anders; Löwdin, Elisabeth; Cars, Otto et al.

Ingår i Antimicrobial Agents and Chemotherapy, s. 128-136, 2007

• DOI för Semimechanistic pharmacokinetic/pharmacodynamic model for assessment of activity of antibacterial agents from time-kill curve experiments

Propensity to release endotoxin after two repeated doses of cefuroxime in an in vitro kinetic model: Higher release after the second dose

Goscinski, Gunilla; Tano, Eva; Löwdin, Elisabeth; Sjölin, Jan

Ingår i Journal of Antimicrobial Chemotherapy, s. 328-333, 2007

• DOI för Propensity to release endotoxin after two repeated doses of cefuroxime in an in vitro kinetic model: Higher release after the second dose

A new in-vitro kinetic model to study the pharmacodynamics of antifungal agents: inhibition of the fungicidal activity of amphotericin B against Candida albicans by voriconazole

Lignell, Anders; Johansson, A.; Löwdin, Elisabeth; Cars, Otto et al.

Ingår i Clinical Microbiology and Infection, s. 613-619, 2007

• DOI för A new in-vitro kinetic model to study the pharmacodynamics of antifungal agents: inhibition of the fungicidal activity of amphotericin B against Candida albicans by voriconazole

Pharmacodynamic effects of telavancin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains in the presence of human albumin or serum and in an in vitro kinetic model

Odenholt, Inga; Löwdin, Elisabeth; Cars, Otto

Ingår i Antimicrobial Agents and Chemotherapy, s. 3311-3316, 2007

• DOI för Pharmacodynamic effects of telavancin against methicillin-resistant and methicillin-susceptible Staphylococcus aureus strains in the presence of human albumin or serum and in an in vitro kinetic model

Pharmacodynamic studies of moxifloxacin and erythromycin against intracellular Legionella pneumophila in an in vitro kinetic model.

Tano, E; Cars, O; Lowdin, E

Ingår i J Antimicrob Chemother, s. 240-2, 2005

Pharmacodynamic studies of amoxicillin against Streptococcus pneumoniae: comparison of a new pharmacokinetically enhanced formulation (2000 mg twice daily) with standard dosage regimens.

Odenholt, Inga; Cars, Otto; Löwdin, Elisabeth

Ingår i J Antimicrob Chemother, s. 1062-6, 2004

Pharmacodynamics of moxifloxacin against Streptococcus pyogenes in an invitro kinetic model.

Odenholt, I; Lowdin, E; Gustafsson, I; Cars, O

Ingår i Antimicrob Agents Chemother, s. 2046, 2002